We are live on
!
Find out more
SO
STRS Ohio Portfolio holdings
AUM
$25.2B
1-Year Est. Return
30.31%
This Fund
S&P 500
This Quarter
Est. Return
+23.23%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$22.9B
AUM Growth
+$3.89B
(+20%)
Cap. Flow
-$22.2M
Cap. Flow
% of AUM
-0.1%
Top 10 Holdings %
Top 10 Hldgs %
23.15%
Holding
2,333
New
311
Increased
958
Reduced
613
Closed
176
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Golub Capital BDC
GBDC
|
+$74.9M |
| 2 |
Keysight
KEYS
|
+$52.1M |
| 3 |
Merck
MRK
|
+$40.9M |
| 4 |
AbbVie
ABBV
|
+$38.6M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$37.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$104M |
| 2 |
Match Group
MTCH
|
+$48.9M |
| 3 |
TransDigm Group
TDG
|
+$43.4M |
| 4 |
Stryker
SYK
|
+$43.1M |
| 5 |
Johnson & Johnson
JNJ
|
+$42.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.57% |
| 2 | Financials | 14.31% |
| 3 | Healthcare | 13.92% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Communication Services | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Dover
DOV
$27.2B
| $27.3M | 0.12% |
282,557
+61,001
| +28% | +$5.63M |
|
202
CME Group
CME
$92.2B
| $27.2M | 0.12% |
167,613
+5,624
| +3% | +$1.01M |
|
203
Fomento Económico Mexicano
FMX
$43.3B
| $27.2M | 0.12% |
439,000
+80,000
| +22% | +$5.09M |
|
204
Healthpeak Properties
DOC
$15.4B
| $27.1M | 0.12% |
982,948
+48,244
| +5% | +$1.23M |
|
205
Public Service Enterprise Group
PEG
$39.8B
| $26.8M | 0.12% |
544,920
+292,968
| +116% | +$14.6M |
|
206
Vistra
VST
$55.1B
| $26.8M | 0.12% |
1,438,441
+483,172
| +51% | +$9.11M |
|
207
Clorox
CLX
$11.6B
| $26.2M | 0.11% |
119,600
+3,820
| +3% | +$763K |
|
208
Automatic Data Processing
ADP
$100B
| $26.1M | 0.11% |
175,554
-49,177
| -22% | -$7.04M |
|
209
lululemon athletica
LULU
$13B
| $25.9M | 0.11% |
83,171
-23,025
| -22% | -$5.89M |
|
210
Ecolab
ECL
$75.6B
| $25.7M | 0.11% |
129,135
-6,300
| -5% | -$1.22M |
|
211
NXP Semiconductors
NXPI
$68B
| $25.7M | 0.11% |
225,000
-75,000
| -25% | -$7.5M |
|
212
Micron Technology
MU
$1.04T
| $25.3M | 0.11% |
491,137
-189,534
| -28% | -$8.94M |
|
213
KeyCorp
KEY
$24.3B
| $25.1M | 0.11% |
2,059,959
+1,747,526
| +559% | +$20.3M |
|
214
O'Reilly Automotive
ORLY
$72.4B
| $25.1M | 0.11% |
891,165
-254,025
| -22% | -$6.64M |
|
215
Estee Lauder
EL
$29B
| $24.9M | 0.11% |
132,029
-5,766
| -4% | -$1.03M |
|
216
CoStar Group
CSGP
$11.3B
| $24.8M | 0.11% |
349,490
-37,650
| -10% | -$2.43M |
|
217
Aecom
ACM
$9.07B
| $24.4M | 0.11% |
649,630
+24,100
| +4% | +$863K |
|
218
Biogen
BIIB
$29.9B
| $24.3M | 0.11% |
90,704
+2,692
| +3% | +$809K |
|
219
GE Aerospace
GE
$367B
| $24.2M | 0.11% |
709,742
-66,580
| -9% | -$2.25M |
|
220
SLB Ltd
SLB
$77.8B
| $24.1M | 0.11% |
1,312,930
+458,587
| +54% | +$8.03M |
|
221
Kilroy Realty
KRC
$4.58B
| $23.7M | 0.1% |
404,330
-53,458
| -12% | -$3.24M |
|
222
Illinois Tool Works
ITW
$81.4B
| $23.5M | 0.1% |
134,201
-8,743
| -6% | -$1.43M |
|
223
Healthcare Realty
HR
$7.42B
| $23.5M | 0.1% |
884,333
-158,716
| -15% | -$4.07M |
|
224
Arthur J. Gallagher & Co
AJG
$63.7B
| $23.3M | 0.1% |
239,389
+11,862
| +5% | +$1.05M |
|
225
First Horizon
FHN
$12.1B
| $23.1M | 0.1% |
2,323,000
+717,411
| +45% | +$6.52M |
|
Similar funds
KK
VAI
UIM
STRS Ohio's Q2 2020 Portfolio in Review
As of Q2 2020, STRS Ohio held 2,333 positions worth $22.9B, up 20% from $19B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
STRS Ohio's Q2 2020 filing shows 311 new, 958 increased, 613 reduced and 176 closed positions. Its largest new stake was RTX Corp: 598,060 shares worth $36.9M. The largest sale was Allergan plc, an estimated $104M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- STRS Ohio's largest Q2 2020 buy was RTX Corp: 598,060 shares worth $36.9M.
- STRS Ohio added most to Golub Capital BDC in Q2 2020, an estimated $74.9M increase.
- STRS Ohio's biggest Q2 2020 reduction was TransDigm Group, cutting an estimated $43.4M.
- STRS Ohio fully exited Allergan plc in Q2 2020, selling an estimated $104M.
- STRS Ohio's ten largest holdings make up 23% of its $22.9B portfolio in Q2 2020.
- STRS Ohio opened 311 new positions and closed 176 in Q2 2020.
- STRS Ohio's portfolio value rose 20% quarter-over-quarter to $22.9B.
Based on STRS Ohio's 13F filing for Q2 2020, filed 23 Jul 2020.